Team:Edinburgh/Project

• home
• team - illuminati
  • official
  • supervisors
  • advisors
  • students
  • environment
  • gallery
• genomic BRIDGEs
  • the protocol
  • submitted parts
  • results
  • future work
  • references
• bacterial BRIDGEs
  • the repressilator
  • red light
  • red sensor
  • blue light
  • blue sensor
  • green light
  • green sensor
  • submitted parts
  • results
  • future work
  • references
• modelling BRIDGEs
  • kappa
  • the genomic model
  • the bacterial model
  • the signalling model
  • tools
  • results
  • future work
  • references
• human BRIDGEs
  • human aspects
  • communication of science
  • terminology research
  • wiki
  • conversations
  • identity
  • collaboration
  • branding research
  • science fiction writing
  • future applications
  • self-reflection
  • the epic
  • results
  • future work
  • references
• lab notes   
  • collaboration
  • attribution
  • BRIDGE
  • red light
  • red sensor
  • blue light
  • blue sensor
  • green light
  • green sensor
  • modelling
  • safety
  • protocols
• acknowledgements

Genomic BRIDGEs

What if synthetic biologists were able to utilise an efficient two-step recombination method for markerless gene insertion and deletion? In 2008, Wei Sun, Shifeng Wang, and Roy Curtiss III of Arizona State University published such a protocol, based on the lambda red recombinase system (a simple method for disrupting chromosomal genes in bacteria such as E. coli using PCR products). The 2010 University of Edinburgh iGEM team has adapted their method to take advantage of the reusability of BioBricks, such that biologists can target critical areas of the E. coli genome with even greater efficiency.

BRIDGE stands for BioBrick Recombination In Direct Genomic Editing. It is an alternative method for inserting BioBricks into the genome by using homologous recombination instead of restriction digestion, with the added bonus of not leaving a marker behind in the product.

Our Project

Our BRIDGE construct will contain two selection markers in order to successfully complete the protocol (described in greater detail here): cat, which confers chloramphenicol resistance, and sacB, which is toxic when the host is grown on sucrose. Both the construct and the desired gene will be inserted by homologous recombination using the lambda red recombinase system. For this we will require up- and down-stream sequences of the genes that we wish to replace.

To prove the principle of BRIDGE we will remove a non-essential, constitutively expressed gene from the E. coli genome and replace it with a well known marker, such as GFP. We also have several genes from a past project idea which we could delete to increase fatty acid synthesis, and further genes we could introduce which will result in the production of long chain alkenes from the excess fatty acids. This is not useful for our current project but it would be a nice way to demonstrate the effectiveness of BRIDGE.

Eventually, we hope that BRIDGE will be used to introduce whole light producer-sensor constructs, to demonstrate its ability for utilisation in further work using BioBricks.

Table of Contents

• The protocol proper, explaining the technical details of BRIDGE.
• The BioBricks we submitted as part of developing the BRIDGE protocol.
• A summary of what we achieved developing the BRIDGE protocol.
• Our vision of the future of the BRIDGE protocol, and where we would like to go next.
• References used throughout the section.